- Lobbying
- Lobbying by Hennepin County Medical Center
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Dennis McGrann | Special Assistant, Chief of Staff Staff Director, Chief of Staff, Special Assistant Committee Staff Director, House Chief of Staff, Special Assistant at the Department of Energy |
Emily Gehrman | Research Assistant |
Hannah Bernhardt | Scheduler |
Johnna White | Staff Assistant |
Andy Burmeister | Legislative Assistant Senate Legislative Assistant |
Emily Tranter | Research Assistant Senate Research Assistant |
Lianne Endo | Deputy Director of Scheduling Senate Deputy Director of Scheduling |
Edward Kim | House Senior Health Policy Adviser, Committee Policy Coordinator, House Senior Policy Adviser |
Alana Petersen | Senate Deputy Chief of Staff, Senate State Director, Senate State Adviser |
Megan Knight | n/a |
Emily (Gehrman) Tranter | n/a |
Rebecca Kanninen | n/a |
Nicholas Kowalski | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Amendment
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Amendment
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues
Medicare
Registration
Issue(s) they said they’d lobby about: FY2011 authorizations, appropriations, and budget policy.
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues
Medicare
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate